As markets remain shaky, technical analysis helps investors find good stock opportunities. Using TipRanks’ Technical Analysis Screener, we have identified three stocks, AppLovin Corp. (APP), Nebius Group (NBIS), and Neurocrine Biosciences (NBIX) that are currently flashing Strong Buy signals. These stocks are showing bullish momentum and present short- to mid-term upside potential, backed by Strong Buy ratings from Wall Street analysts.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Notably, technical analysis studies a stock’s past price movements and trading volume to predict future trends. It uses tools like moving averages, RSI, and chart patterns to identify Buy or Sell signals. Within this context, TipRanks’ Technical Analysis tool simplifies this process by combining multiple indicators into one easy-to-understand dashboard for users. Let’s dive into the details.
Is AppLovin a Good Stock to Buy?
AppLovin provides AI-powered solutions designed to help companies expand their advertising reach.
According to TipRanks’ technical analysis, APP stock is currently in an upward trend. It holds a Strong Buy rating based on both overall technical consensus and moving average indicators. One key indicator, the Rate of Change (ROC), which tracks momentum by measuring the percentage change in price over a set period, currently stands at 7.6 for APP. Since an ROC above zero suggests upward momentum, this signals a Buy for the stock.
Is NBIS a Strong Buy?
Nebius Group is a technology infrastructure company specializing in cloud computing and AI-powered platform solutions for businesses.
According to TipRanks’ technical analysis, NBIS stock holds a Strong Buy consensus, backed by 16 bullish and five neutral signals. The stock also holds a Strong Buy rating based on moving average consensus, supported by all 12 bullish signals, indicating strong upward momentum.
Is Neurocrine a Buy?
Neurocrine Biosciences is a biotech company focused on developing and commercializing treatments for neurological, neuroendocrine, and psychiatric disorders.
From a technical analysis perspective, NBIX is rated a Strong Buy, backed by 16 bullish and six neutral signals. It also earns a Strong Buy rating based on the moving average consensus. Additionally, the Williams %R, a tool that signals whether a stock is overbought or oversold, also shows a Buy signal for NBIX.